{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-046909","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2025-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.691531+00:00","generated_at":"2026-05-20T18:36:05.287898+00:00","sec_items":["1.01","2.03","3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Onconetix receives second Nasdaq delisting notice for late 10-Q; hearing set May 27","bullets":["Received Nasdaq deficiency notice May 20 for failure to timely file Q1 2025 10-Q, adding to existing non-compliance for late 10-K.","Company also faces delisting due to bid price below $0.10 for 10 consecutive days; hearing before Nasdaq Panel scheduled May 27.","Issued $294,117.65 promissory note to Keystone Capital Partners with OID of $44,117.65; due Feb 2026 or upon equity line proceeds.","No assurance Panel will grant stay; stock delisting would follow if unfavorable decision.","Company intends to file 10-K and 10-Q as promptly as possible to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-046909","json":"https://secwatch.observer/filing/0001213900-25-046909.json","markdown":"https://secwatch.observer/filing/0001213900-25-046909.md","text":"https://secwatch.observer/filing/0001213900-25-046909.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025046909/0001213900-25-046909-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025046909/ea0243287-8k_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T18:36:05.287898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bf88284493228d69bf7513cd53cf73fe225b621a","claim":"Onconetix, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 20, 2025, Onconetix, Inc. (the “ Company ”) received a deficiency notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Listing Rules ”) as set forth in Listing Rule 5250(c)(1) given the Company’s failure to timely file its Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the “ 10-Q ”), and that this matter serves as an additional basis for delisting the Company’s securities from Nasdaq. As previously reported in the Current Report on Form 8-K filed with the Secur","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025046909/0001213900-25-046909-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}